Novato, CA, June 18, 2014 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced that Emil D. Kakkis, M.D., Ph.D., the company's Chief Executive Officer, will be presenting at the JMP Securities Healthcare Conference on June 25, 2014 at 2:30pm ET at the Westin New York Grand Central.
Help employers find you! Check out all the jobs and post your resume.
